Tarsier-04
Inflammatory ocular disease (specific indication undisclosed)
Phase 3Active
Key Facts
Indication
Inflammatory ocular disease (specific indication undisclosed)
Phase
Phase 3
Status
Active
Company
About Tarsier Pharma
Innovative immunomodulator platform for ocular inflammatory diseases, advancing multiple candidates toward late‑stage trials.
View full company profile